Want to track GUD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Knight Therapeutics Inc. (GUD) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.03B
Trailing P/E (ttm) 75.05
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 1.98
Price/Book (mrq) 1.36
Enterprise Value/Revenue 1.87
Enterprise Value/EBITDA 11.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 68.28K
Average volume (90 days) 82.87K
Price summary
52-Week low 5.66
52-Week high 11.16
Beta -
50-Day moving average 10.23
200-Day moving average 9.18
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.03%
Operating margin 0.05%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 5.57
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.12
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 2.28%
Book value per share (mrq) 8.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
